Stay updated on HOPE-B: AMT-061 Clinical Trial
Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.

Latest updates to the HOPE-B: AMT-061 Clinical Trial page
- Check4 days agoChange DetectedThe HOPE-B record presents details of a completed Phase 3 trial investigating AMT-061 gene therapy for adults with severe or moderately severe hemophilia B. It includes the study plan and outcome measures, participant criteria, trial locations, publications, and study documents.SummaryDifference77%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden message.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appeared, and the site revision number was updated.SummaryDifference1%

- Check39 days agoChange DetectedThe page remains a 403 Forbidden error page, with the displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error with a simple header and a Home button. This replaces the previously visible study record content and documents.SummaryDifference20%

- Check60 days agoChange DetectedThe revision label on the page was updated from v3.6.6 to v3.7.0, indicating a new release of the page's documentation or underlying CMS. This change does not alter the visible content or core information on the study page.SummaryDifference0.0%

Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.